C32.1 - Malignant neoplasm of supraglottis

Version 2023
ICD-10:C32.1
Short Description:Malignant neoplasm of supraglottis
Long Description:Malignant neoplasm of supraglottis
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of respiratory and intrathoracic organs (C30-C39)
      • Malignant neoplasm of larynx (C32)

C32.1 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of supraglottis. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic aryepiglottic fold laryngeal aspect ; Neoplasm, neoplastic cartilage (articular) (joint) NEC [See Also: Neoplasm, bone] epiglottis ; Neoplasm, neoplastic cord (true) (vocal) false ; Neoplasm, neoplastic epiglottis ; Neoplasm, neoplastic epiglottis posterior (laryngeal) surface ; Neoplasm, neoplastic epiglottis suprahyoid portion ; Neoplasm, neoplastic interarytenoid fold laryngeal aspect ; etc

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Type 2 Excludes

Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C32.1161.1 - Malig neo supraglottis

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »aryepiglottic fold
    »laryngeal aspect
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »cartilage (articular) (joint) NEC [See Also: Neoplasm, bone]
    »epiglottis
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »cord (true) (vocal)
    »false
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »epiglottis
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »epiglottis
    »posterior (laryngeal) surface
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »epiglottis
    »suprahyoid portion
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »interarytenoid fold
    »laryngeal aspect
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »larynx, laryngeal NEC
    »aryepiglottic fold
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »larynx, laryngeal NEC
    »extrinsic NEC
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »larynx, laryngeal NEC
    »interarytenoid fold
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »larynx, laryngeal NEC
    »ventricular band
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »supraglottis
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »ventricular band of larynx
C32.1C78.39D02.0D14.1D38.0D49.1
»Neoplasm, neoplastic
  »vocal cords (true)
    »false
C32.1C78.39D02.0D14.1D38.0D49.1

Patient Education


Throat Cancer

Throat cancer is a type of head and neck cancer. Throat cancer has different names, depending on which part of the throat is affected. The different parts of your throat are called the oropharynx, the hypopharynx, the nasopharynx, and the larynx, or voice box.

The main risk factors for throat cancer are using tobacco heavy drinking. Certain types of throat cancer also have other risk factors. For example, having HPV is a risk factor for oropharyngeal cancer.

Symptoms of throat cancer may include:

To diagnose throat cancers, doctors may do a physical exam and history, imaging tests, and a biopsy. You may also need other tests, depending on the type of cancer. Treatments include surgery, radiation therapy, and chemotherapy. Treatment for some types of throat cancer may also include targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History